共 50 条
- [3] Spotlight on Lenalidomide in Relapsed or Refractory Multiple Myeloma [J]. BioDrugs, 2011, 25 : 333 - 337
- [4] Lenalidomide for the treatment of relapsed or refractory multiple myeloma [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 22 - 24
- [5] Spotlight on Lenalidomide in Relapsed or Refractory Multiple Myeloma [J]. BIODRUGS, 2011, 25 (05) : 333 - 337
- [7] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma [J]. Blood Cancer Journal, 2014, 4 : e182 - e182
- [8] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma [J]. BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
- [9] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma [J]. Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
- [10] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375